Uji Aktivitas Senyawa Panduratin A dan Turunannya terhadap Reseptor Estrogen Alfa pada Kanker Payudara Secara In Silico

Firda Aulia Jannati, Hilda Aprilia Wisnuwardhani, Taufik Muhammad Fakih

Abstract


ABSTRACT: Breast cancer is the leading cause of death in women caused by cancer. Panduratin compound derived from Boesenbergia pandurate is a compound that has anticancer activity on MCF-7 breast cancer and HT-29 colon cancer cells. The purpose of this study was to determine the interaction and affinity between the panduratin compound to alpha estrogen receptor. In this study, identification of the physicochemical properties of the Panduratin tes compound was carried out using ChemBioDraw. The Panduratin compound was geometrically optimized using Gauss View software version 5.0.8 and Gaussian version 09. The conformation of the best Panduratin compound were continued to docking simulation stage for the Alpha Estrogen Receptor which had been separated from its natural ligand and was validated using MGL Tools 1.5.6 software which has been equipped with Autodock Tools version 4.2. Analysis of the molecular docking result was conducted using BIOVIA Discovery Studio software. Toxicity prediction were performed using Toxtree software by looking at the Cramer Rules, The TCC Decision Tree and Benigni/Bossa Rulebase parameters. The result showed that Panduratin F compounds have a better affinity than Panduratin A, Panduratin B1, Panduratin C, Panduratin D, Panduratin E, Panduratin G and Panduratin H compunds and their natural ligan (4-hydroxytamoxifen) with a free energy of binding value  -12,72 Kcal/mol and inhibiton constant 436,45 pM. So, Panduratin F compound can be used as a breast anticancer candidate.

Keywords: Breast cancer, estrogen receptor alpha, panduratin, in silico.

ABSTRAK: Kanker payudara merupakan penyebab kematian utama pada wanita yang disebabkan oleh kanker. Senyawa Panduratin berasal dari Boesenbergia pandurate, merupakan senyawa yang memiliki aktivitas antikanker pada sel kanker payudara MCF-7 dan kanker kolon HT-29. Tujuan dari penelitian ini untuk mengetahui interaksi dan afinitas antara senyawa panduratin dengan reseptor estrogen alfa. Pada penelitian ini dilakukan identifikasi sifat fisikokimia pada senyawa uji Panduratin menggunakan ChemBioDraw. Senyawa uji Panduratin dilakukan optimasi geometri menggunakan software Gauss View versi 5.0.8 dan Gaussian versi 09. Konformasi senyawa uji Panduratin terbaik dilanjutkan ke tahap simulasi docking terhadap reseptor estrogen alfa yang telah dipisahkan dengan ligan alaminya dan telah di validasi menggunakan software MGL Tools 1.5.6 yang telah dilengkapi dengan Autodock Tools versi 4.2. dan dilakukan analisis hasil docking menggunakan software BIOVIA Discovery Studio, senyawa dilakukan prediksi toksisitas menggunakan software Toxtree dengan melihat parameter Cramer rules, kroes TCC decision tree dan benigni/bossa rulebase. Dari hasil molecular docking dapat disimpulkan bahwa senyawa Panduratin F memiliki afinitas yang lebih baik dibandingkan senyawa Panduratin A, Panduratin B, Panduratin C, Panduratin D, Panduratin E, Panduratin G, Panduratin H dan ligan alaminya (hydroxytamoxifen) dengan nilai energi bebas ikatan -12,72 Kcal/mol dan konstanta inhibisi 436,45 pM sehingga dapat dijadikan sebagai referensi obat antikanker payudara.

Kata Kunci: Kanker payudara, reseptor estrogen alfa, panduratin, in silico.


Keywords


Kanker payudara, reseptor estrogen alfa, panduratin, in silico.

Full Text:

PDF

References


Aruminingsih, S.I., Choridah, L., Supriatna, Y., 2015. Perbandingan Kejadian Fatty Liver pada Ultrasonografi Penderita Kanker Payudara Dengan dan Tanpa Terapi Tamoxifen. J. Radiol. Indones. 1, 23–30.

Bi, H.M., Hu, J.P., You, F.Y., Gao, M.M., Dong, C.H., 2014. QSAR studies of biological activity with phenylpropyl aldehyde thiosemicarbazone compounds. Asian J. Chem. 26.

Eng-Chong, T., Yean-Kee, L., Chin-Fei, C., Choon-Han, H., Sher-Ming, W., Li-Ping, C.T., Gen-Teck, F., Khalid, N., Abd Rahman, N., Karsani, S.A., Othman, S., Othman, R., Yusof, R., 2012. Boesenbergia rotunda: From ethnomedicine to drug discovery. Evidence-based Complement. Altern. Med. 2012.

Kartasasmita, R.E., Herowati, R., Harmastuti, N., Gusdinar, T., 2009. QUERCETIN DERIVATIVES DOCKING BASED ON STUDY OF FLAVONOIDS INTERACTION TO CYCLOOXYGENASE-2 Docking Turunan Kuersetin Berdasarkan Studi Interaksi Flavonoid Terhadap Enzim. Indo.J.chem.

Kemenkes RI, 2019. Artikel Hari Kanker Sedunia 2019. Hari Kanker Sedunia 2019.

Kirana, C., Jones, G.P., Record, I.R., McIntosh, G.H., 2007. Anticancer properties of panduratin A isolated from Boesenbergia pandurata (Zingiberaceae). J. Nat. Med. 61, 131–137.

Limpens, M., 2018. Kanker. PodoPost 31, 5–5.

Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J., 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev.

Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J., 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3–25.

Muchtaridi, M., Megantara, S., Dermawan, D., Yusuf, M., 2019. Antagonistic mechanism of α-mangostin derivatives against human estrogen receptor α of breast cancer using molecular dynamics simulation. Rasayan J. Chem. 12, 1927–1934.

Paterni, Iliaria. Granchi, C., Katzenellenbogen, J., Minutolo, F., 2011. Estrogen Receptors Alpha and Beta Subtype-Selective Ligands and Clinical Potential 18, 1492–1501.

Smoot, B., Wampler, M., Topp, K.S., 2009. Breast cancer treatments and complications: Implications for rehabilitation. Rehabil. Oncol. 27, 16–26.

Fauzi, Nur Muhammad. (2021). Uji Kualitatif dan Uji Aktivitas Antioksidan Ekstrak Etanolik Buah Maja (Aegle Marmelos (L.)Correa) dengan Metode DPPH. Jurnal Riset Farmasi, 1(1), 1-8.




DOI: http://dx.doi.org/10.29313/.v0i0.29610

Flag Counter